Why Big Pharma Pushes COVID-19 Vaccines on Recovered Individuals
Why Big Pharma Pushes COVID-19 Vaccines on Recovered Individuals
Understanding the nature of viruses is crucial to gaining insight into why Big Pharma continues to push COVID-19 vaccines even on individuals who have recovered from the disease. This article explores the reasons behind this aggressive vaccination campaign and the broader implications for public health.
Viruses and Immunity Explained
Some viruses, such as measles, chickenpox, and smallpox, mutate and lose their ability to create disease. Once infected and recovered, individuals develop lifelong immunity. However, viruses like influenza, SARS-CoV-2 (the cause of COVID-19), and others continue to mutate, leading to the emergence of new strains. This continuous mutation means that getting infected does not provide long-term immunity against the new variants.
COVID-19, specifically, is a novel virus that causes disease after mutating. This means that getting the disease does not ensure protection from future variants. In fact, researchers have observed that immunity following infection can be short-lived, necessitating periodic booster doses.
The Role of Big Pharma
Big Pharma plays a significant role in shaping public health narratives, particularly when it comes to vaccines. These companies sponsor and control the indoctrination process, often starting in medical schools. Studies and data are manipulated to promote specific information and agendas. Medical students, despite their good intentions, are often brainwashed and become advocates for these questionable vaccines.
The primary goal of Big Pharma is profit, not public health. By altering government policies and preventing lawsuits against vaccine damage, they ensure their dominance in the industry. Ultimately, this results in a focus on sustaining the health crisis rather than addressing it, as the 'sickness business' is highly lucrative.
Reinfection and Vaccine Efficacy
Recent data suggests that receiving multiple mRNA vaccination doses may increase the likelihood of reinfection with SARS-CoV-2. This finding is largely censored in the United States, but international studies provide a clearer picture. The persistent mutation of the virus means that the current vaccines are not as effective in protecting against new variants compared to initial infections.
One key concern is the potential long-term effects of the vaccines themselves. The ingredients in the vaccines, particularly the mRNA, are still not fully understood. Some suggest that the real 'poison' in the vaccines is the mRNA itself, which could lead to various health issues. Additionally, the inclusion of nanotechnology and tracking methods, like Bluetooth identifiers, raises ethical concerns about privacy and control.
Another significant point is the timing of vaccine rollouts in relation to 5G deployments. Many countries rolled out 5G towers during lockdowns, raising suspicions about a potential connection between the technology and the pandemic narrative. Further investigations into the 'covid enquiries' are necessary to understand the full extent of the damage caused by the current vaccination strategies and public health policies.
Conclusion
The aggressive push for COVID-19 vaccines, even on individuals who have already recovered, reflects a broader strategy by Big Pharma to maintain control over public health agendas. Understanding the nature of viral evolution and the interests of vaccine manufacturers is essential for making informed decisions about public health policies.